Augmenting amyloid PET interpretations with quantitative information improves consistency of cerebral amyloid detection

James B. Leverenz, Osama Sabri, Ana M. Catafau, Henryk Barthel, John Seibyl, Bernardino Ghetti, James W. Ironside, Santiago Bullich, Walter J. Schulz-Schaeffer, Anja Hoffman, Cleveland Clinic Neurological Institute, Cleveland, OH, USA; University of Leipzig, Leipzig, Germany; Piramal Imaging GmbH, Berlin, Germany; Molecular NeuroImaging, New Haven, CT, USA; Indiana University School of Medicine, Indianapolis, IN, USA; University of Edinburgh, Edinburgh, Scotland; Georg-August University G€ottingen, G€ottingen, Germany; Bayer Pharma AG, Berlin, Germany. Contact e-mail: leverej@ccf.org